Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-13,948
Closed -$820K 999
2022
Q2
$820K Buy
13,948
+2,887
+26% +$176K ﹤0.01% 988
2022
Q1
$741K Hold
11,061
﹤0.01% 996
2021
Q4
$734K Sell
11,061
-3,104
-22% -$194K ﹤0.01% 959
2021
Q3
$843K Hold
14,165
﹤0.01% 945
2021
Q2
$991K Hold
14,165
﹤0.01% 809
2021
Q1
$952K Hold
14,165
﹤0.01% 896
2020
Q4
$877K Hold
14,165
﹤0.01% 869
2020
Q3
$733K Hold
14,165
﹤0.01% 868
2020
Q2
$774K Sell
14,165
-5,835
-29% -$331K ﹤0.01% 895
2020
Q1
$1.21M Sell
20,000
-23,613
-54% -$1.79M 0.01% 814
2019
Q4
$3.54M Buy
43,613
+23,613
+118% +$1.95M 0.02% 543
2019
Q3
$1.75M Hold
20,000
0.01% 665
2019
Q2
$1.66M Buy
+20,000
New +$1.65M 0.01% 696

Other funds holding ALE

Aviva's ALE Position: Q3 2022 in Review

Aviva sold out of Allete (ALE) in Q3 2022, closing a stake of 13,948 shares — an estimated $820K sold.

Aviva first reported a position in ALE in Q2 2019 and held it in 13 quarters. The position peaked at $3.54M in Q4 2019. 284 funds tracked by Wall St. Rank hold ALE as of Q3 2022.

  • Aviva reported no remaining Allete position as of Q3 2022 after selling out during the quarter.
  • Aviva sold 13,948 Allete shares in Q3 2022, an estimated $820K.
  • Aviva first reported a position in Allete in Q2 2019 and held it in 13 quarters.
  • Aviva's Allete position peaked at $3.54M in Q4 2019.
  • 284 funds tracked by Wall St. Rank held Allete as of Q3 2022.

Based on Aviva's 13F filing for Q3 2022, filed 14 Nov 2022.